most sensitive companies to a cure or vaccine are the banks, other than drug companies: schutz
Published 3 years ago • 2.8K plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
2:29
covid-19 vaccines are what's behind bank stocks' strength: mendon's schutz
-
4:01
here's why mendon capital advisors' anton schutz likes regional banks
-
3:13
mendon's anton schutz on bank stress test results
-
4:56
these banks failed because there was a run on the banks, says mendon's anton schutz
-
3:36
curevac ceo on the company's ipo and covid-19 vaccine research
-
3:42
mendon capital's anton schutz on the bank stocks to watch this earnings season
-
50:19
how high will stocks go?
-
4:46
kevin o'leary on why he doesn't own big bank stock
-
4:06
this is the most destructive wealth event in the history of crypto, says the block's frank chaparro
-
3:54
companies have limited options when convincing covid-19 vaccine skeptics
-
5:22
a market pullback is healthy at this stage, says defiance etfs ceo sylvia jablonski
-
2:18
nine biopharma ceos pledge to make safety the main focus in covid-19 vaccine development
-
2:52
the equity market tightening will do most of the fed’s work for it, says axonic’s cecchini
-
3:41
mendon capital's anton schutz likes mid-cap banks
-
2:21
schutz: smaller banks are doing smarter m&a deals
-
3:28
economist: boj to tread cautiously when trimming bond purchasesーnhk world-japan news
-
2:35
ubs upgrades pnc financial to buy
-
3:45
'rates will go higher because there's more stimulus coming': mendon capital's anton schutz
-
2:06
safety in big tech is a sign of fragility, says axonic's peter cecchini
-
3:15
schutz: bank do as a whole benefit from rising rates
-
4:18
may is a reasonable time to open vaccine eligibility: atlantic health ceo
-
6:10
chips act to ‘scale up’ the smartphone market, akoustis ceo says